These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33453318)

  • 1. A dynamical system for the IGF1-AKT signaling pathway in skeletal muscle adaptation.
    Villota-Narvaez Y; Garzon-Alvarado DA; Ramirez-Martinez AM
    Biosystems; 2021 Apr; 202():104355. PubMed ID: 33453318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
    Bacurau AV; Jannig PR; de Moraes WM; Cunha TF; Medeiros A; Barberi L; Coelho MA; Bacurau RF; Ugrinowitsch C; Musarò A; Brum PC
    Int J Cardiol; 2016 Jul; 214():137-47. PubMed ID: 27060274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats.
    Liu M; Stevens-Lapsley JE; Jayaraman A; Ye F; Conover C; Walter GA; Bose P; Thompson FJ; Borst SE; Vandenborne K
    Eur J Appl Physiol; 2010 Jul; 109(4):709-20. PubMed ID: 20213470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isometric resistance exercise fails to counteract skeletal muscle atrophy processes during the initial stages of unloading.
    Haddad F; Adams GR; Bodell PW; Baldwin KM
    J Appl Physiol (1985); 2006 Feb; 100(2):433-41. PubMed ID: 16239603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal alterations in protein signaling cascades during recovery from muscle atrophy.
    Childs TE; Spangenburg EE; Vyas DR; Booth FW
    Am J Physiol Cell Physiol; 2003 Aug; 285(2):C391-8. PubMed ID: 12711594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Nat Cell Biol; 2003 Feb; 5(2):87-90. PubMed ID: 12563267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.
    van Langenberg DR; Della Gatta P; Hill B; Zacharewicz E; Gibson PR; Russell AP
    J Crohns Colitis; 2014 Jul; 8(7):626-34. PubMed ID: 24332699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.
    Weeks KL; Bernardo BC; Ooi JYY; Patterson NL; McMullen JR
    Adv Exp Med Biol; 2017; 1000():187-210. PubMed ID: 29098623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of IGF-1 Signaling in Skeletal Muscle Atrophy.
    Timmer LT; Hoogaars WMH; Jaspers RT
    Adv Exp Med Biol; 2018; 1088():109-137. PubMed ID: 30390250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
    Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration-based training: A new mode of training in senescent rats improving performance and left ventricular and muscle functions.
    Launay T; Momken I; Carreira S; Mougenot N; Zhou XL; De Koning L; Niel R; Riou B; Billat V; Besse S
    Exp Gerontol; 2017 Sep; 95():71-76. PubMed ID: 28479388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle hypertrophy and atrophy signaling pathways.
    Glass DJ
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-scale mechanobiological model for skeletal muscle hypertrophy.
    Villota-Narvaez Y; Garzón-Alvarado DA; Röhrle O; Ramírez-Martínez AM
    Front Physiol; 2022; 13():899784. PubMed ID: 36277181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of skeletal muscle mass: getting the "AKT" together.
    Nader GA
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1985-96. PubMed ID: 16125108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Age on Skeletal Muscle Hypertrophy and Atrophy Signaling: Established Paradigms and Unexpected Links.
    Lee EJ; Neppl RL
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34063658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass.
    Frost RA; Lang CH
    J Appl Physiol (1985); 2007 Jul; 103(1):378-87. PubMed ID: 17332274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular events controlling skeletal muscle mass in response to altered use.
    Favier FB; Benoit H; Freyssenet D
    Pflugers Arch; 2008 Jun; 456(3):587-600. PubMed ID: 18193272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.